Novavax (NVAX) Earnings Date, Estimates & Call Transcripts $13.61 -0.81 (-5.62%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 8) $0.99 Missed By -$0.83 Consensus EPS (Aug. 8) $1.82 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K Filing Get Novavax Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVAX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVAX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVAX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia knows it can’t stand still as AI continues to grow at an exponential rate. That’s why CEO Jensen Huang consistently has his company ahead of the curve when it comes to artificial intelligence. Nvidia’s added $2 trillion in market cap in 2024.I call these Nvidia’s “Silent Partners.” Novavax Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($1.48)($0.85)($1.09) Q2 20242($1.23)($0.92)($1.08) Q3 20243($1.06)($0.58)($0.77) Q4 20243$1.50$2.72$2.01 FY 202411($2.27)$0.37($0.93) Q1 20251($0.69)($0.69)($0.69) Q2 20251($0.66)($0.66)($0.66) Q3 20251($0.30)($0.30)($0.30) Q4 20251$1.49$1.49$1.49 FY 20254($0.16)($0.16)($0.16) Q1 20261($0.45)($0.45)($0.45) NVAX Earnings Date and InformationNovavax last posted its quarterly earnings results on August 8th, 2024. The biopharmaceutical company reported $0.99 earnings per share for the quarter, missing analysts' consensus estimates of $1.82 by $0.83. The business had revenue of $415.50 million for the quarter, compared to analysts' expectations of $458.57 million. Its revenue for the quarter was down 2.1% compared to the same quarter last year. Novavax has generated ($3.17) earnings per share over the last year (($3.17) diluted earnings per share). Earnings for Novavax are expected to grow in the coming year, from ($1.04) to ($0.41) per share. Novavax has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Novavax Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/8/2024Q2 2024$1.82$0.99($0.83)$0.99$458.57 million$415.50 million 5/10/2024Q1 2024($1.04)($1.05)($0.01)($1.05)$71.32 million$93.90 million 2/28/2024Q4 2023($0.49)($1.44)($0.95)($1.44)$310.96 million$291.34 million 11/9/2023Q3 2023($1.82)($1.26)+$0.56($1.26)$171.04 million$187.00 million 8/8/2023Q2 2023($1.24)$0.58+$1.82$0.58$264.16 million$424.40 million 5/9/2023Q1 2023($3.38)($3.41)($0.03)($3.41)$94.52 million$81.00 million Get the Latest News and Ratings for NVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. 2/28/2023Q4 2022($0.92)($2.28)($1.36)($2.28)$383.14 million$357.40 million 11/8/2022Q3 2022$2.21($2.15)($4.36)($2.15)$555.50 million$734.58 million 8/8/2022Q2 2022$5.51($6.53)($12.04)($6.53)$1.02 billion$186.00 million 5/9/2022Q1 2022$3.33$2.56($0.77)$2.56$845.20 million$703.97 million 2/28/2022Q4 2021($1.43)($11.18)($9.75)($11.18)$331.79 million$222.20 million 11/4/2021Q3 2021($4.04)($4.31)($0.27)($4.31)$347.34 million$178.80 million 8/5/2021Q2 2021($3.63)($4.75)($1.12)($4.75)$370.80 million$298.02 million 5/10/2021Q1 2021($2.65)($3.05)($0.40)($3.05)$233.90 million$447.00 million 3/1/2021Q4 2020($1.53)($2.70)($1.17)($2.70)$202.44 million$279.66 million 11/9/2020Q3 2020$2.36($3.21)($5.57)($3.21)$230.56 million$157.00 million 8/10/2020Q2 2020($0.60)($0.30)+$0.30($0.30)$5.67 million$35.50 million 5/11/2020Q1 2020($0.67)($0.58)+$0.09($0.58)$3.50 million$3.38 million 3/11/2020Q4 2019($1.06)($1.13)($0.07)($1.13)$3.99 million$8.82 million 11/7/2019Q3 2019($0.98)($0.74)+$0.24($1.32)$4.40 million$2.51 million Novavax Earnings - Frequently Asked Questions When is Novavax's earnings date? Novavax has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on NVAX's earnings history. What guidance has Novavax issued on next quarter's earnings? Novavax updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $700.0 million-$800.0 million, compared to the consensus revenue estimate of $936.4 million. Did Novavax beat their earnings estimates last quarter? In the previous quarter, Novavax (NASDAQ:NVAX) missed the analysts' consensus estimate of $1.82 by $0.83 with a reported earnings per share (EPS) of $0.99. Learn more on analysts' earnings estimate vs. NVAX's actual earnings. How can I listen to Novavax's earnings conference call? The conference call for Novavax's latest earnings report can be listened to online. Listen to Conference Call How can I read Novavax's conference call transcript? The conference call transcript for Novavax's latest earnings report can be read online. Read Transcript How can I view Novavax's earnings report? Novavax's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Novavax generate each year? Novavax (NASDAQ:NVAX) has a recorded annual revenue of $560.34 million. How much profit does Novavax generate each year? Novavax (NASDAQ:NVAX) has a recorded net income of -$545.06 million. NVAX has generated -$3.17 earnings per share over the last four quarters. What is Novavax's EPS forecast for next year? Novavax's earnings are expected to grow from ($1.04) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies: IOVA Earnings TWST Earnings RLAY Earnings ADPT Earnings KOD Earnings CRSP Earnings DNLI Earnings EXEL Earnings HALO Earnings IONS Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:NVAX) was last updated on 10/5/2024 by MarketBeat.com Staff From Our PartnersAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed ...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.